Read the full stored bill text
SB1538 - 572R - H Ver
House Engrossed
Senate Bill
moving
violation; citation; AZPOST-certified officer
(now: moving
violations; AZPOST-certified officer; prosecutors)
(now:� controlled
substances; approval; workers' compensation)
State of Arizona
Senate
Fifty-seventh Legislature
Second Regular Session
2026
SENATE BILL 1538
AN
ACT
Amending title 23, chapter 6, article 4,
Arizona Revised Statutes, by adding section 23-973; amending section 36-2511,
Arizona Revised Statutes, as amended by laws 2021, chapter 61, section 12;
amending section 36-2511, Arizona Revised Statutes, as amended by laws
2025, chapter 231, section 1; amending title 36, chapter 27, article 2, Arizona
Revised Statutes, by adding section 36-2517.03; relating to post-traumatic
stress medicines.
(TEXT OF BILL BEGINS ON NEXT PAGE)
Be it enacted by the Legislature of the State of Arizona:
Section 1. Title 23, chapter 6, article 4,
Arizona Revised Statutes, is amended by adding section 23-973, to read:
START_STATUTE
23-973.
Coverage; midomafetamine; firefighters; peace officers; post-traumatic
stress disorder; annual report; definitions
A. Employers shall provide workers'
compensation coverage to firefighters and certified peace officers who have
been diagnosed with post-traumatic stress disorder by a licensed mental
health professional and who have an accepted workers' compensation claim for
post-traumatic stress disorder under this title. If an independent
medical examination reveals that a treatment protocol of Midomafetamine is
deemed a reasonable and necessary treatment and follows the treatment
guidelines established by the commission, workers' compensation coverage may
include one complete course of a treatment protocol of Midomafetamine as
prescribed by a psychiatrist.
B. Midomafetamine prescribed under
this section must meet the requirements under title 36, chapter 27 for a
controlled substance.
C. On or before January 1, 2029 and
each January 1 thereafter, the commission shall submit to the joint legislative
budget committee a report of the costs of treatment for Midomafetamine under
this section for firefighters and certified peace officers.
D. For the purposes of this section:
1. "Certified peace
officer" has the same meaning prescribed in section 38-842.
2. "Firefighter" means a
professional firefighter who is a member of a city, town, county or fire
district fire department.
3. "Licensed mental health
professional" means an individual who specializes in trauma and crisis,
who uses evidence-based treatment options and who is licensed as either:
(
a
) A
psychiatrist pursuant to title 32, chapter 13 or 17.
(
b
) A
psychologist pursuant to title 32, chapter 19.1.
4. "Treatment protocol of
Midomafetamine" means a process of treatment that has received approval
from the United States Food and Drug
Administration for post-traumatic stress disorder and that uses
Midomafetamine in conjunction with therapy sessions.
END_STATUTE
Sec. 2. Section 36-2511, Arizona Revised
Statutes, as amended by Laws 2021, chapter 61, section 12, is amended to read:
START_STATUTE
36-2511.
Nomenclature
The controlled substances listed or to be listed in the
schedules in sections 36-2512, 36-2513, 36-2514, 36-2515,
36-2516
,
and
36-2517
and 36-2517.03
or the rules adopted pursuant to this
article are included by whatever official, common, usual, chemical or trade
name designated.
END_STATUTE
Sec. 3. Section 36-2511, Arizona Revised Statutes, as amended by Laws 2025, chapter 231, section
1, is amended to read:
START_STATUTE
36-2511.
Nomenclature
The controlled substances listed or to be listed in the
schedules in sections 36-2512, 36-2513, 36-2514, 36-2515,
36-2516, 36-2517
,
and
36-2517.02
and 36-2517.03
or the rules adopted pursuant to
this article are included by whatever official, common, usual, chemical or
trade name designated.
END_STATUTE
Sec. 4. Title 36, chapter 27, article 2,
Arizona Revised Statutes, is amended by adding section 36-2517.03, to read:
START_STATUTE
36-2517.03.
United States food and drug administration; approved medication;
rescheduling
Any compound, mixture or preparation that
contains 3, 4-methylenedioxymethamphetamine and that is approved by the
United States food and drug administration and rescheduled by the United States
drug enforcement administration to a schedule other than schedule I of the
controlled substances act (P.L. 91-513; 84 Stat. 1242; 21 United States
Code sections 801 through 904) is a controlled substance for the purposes of
this chapter and may be prescribed in this state.
END_STATUTE
Sec. 5.
Conditional enactment; notice; industrial
commission duties
A. Section 23-973,
Arizona Revised Statutes, as added by this act, does not become effective
unless on or before January 1, 2029 the United States food and drug
administration approves the use of midomafetamine to treat post-traumatic
stress disorder.
B. The executive director
of the Arizona state board of pharmacy shall notify the director of the Arizona
legislative council and the director of the industrial commission of Arizona in
writing on or before February 1, 2029 either:
1. Of the date on which the
condition was met.
2. That the condition was
not met.
C. On notification from the
Arizona state board of pharmacy that the condition has been met, the industrial
commission of Arizona shall assign reimbursement values in its schedule of fees
and publish guidelines on billing and reimbursement practices for
midomafetamine.
Sec. 6.
Conditional
enactments; notice
A. Section 36-2511, Arizona
Revised Statutes, as amended by Laws 2021, chapter 61, section 12 and this act,
and section 36-2517.03, Arizona Revised Statutes, as added by this act, do not
become effective unless on or before January 1, 2029 a 3, 4-methylenedioxymethamphetamine
investigational product is newly approved as a prescription medication pursuant
to 21 United States Code section 355 and is controlled under a federal interim
final rule issued pursuant to 21 United States Code section 811(j) and
published in the Federal Register.
B. Section 36-2511, Arizona
Revised Statutes, as amended by Laws 2025, chapter 231, section 1 and this act,
does not become effective unless both the condition prescribed by Laws 2025,
chapter 231, section 5, subsection A is met and on or before January 1, 2029 a
3, 4-methylenedioxymethamphetamine investigational product is newly
approved as a prescription medication pursuant to 21 United States Code section
355 and is controlled under a federal interim final rule issued pursuant to 21
United States Code section 811(j) and published in the Federal Register.
C. The executive director
of the Arizona state board of pharmacy shall notify in writing the director of
the Arizona legislative council on or before February 1, 2029 either:
1. Of the date on which the
condition was met.
2. That the condition was
not met.
Sec. 7.
Federal monies; research; midomafetamine;
Arizona State University medical school; delayed repeal
A. If federal monies are
disbursed to this state for midomafetamine research, the federal monies must be
transferred to Arizona State University's medical school to conduct
midomafetamine research.
B. This section is repealed
from and after December 31, 2028.